Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02853981
Other study ID # GEC_LTx_Surg_216
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received March 11, 2016
Last updated January 17, 2018
Start date January 2015
Est. completion date September 2016

Study information

Verified date January 2018
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether clamp-crush technique for liver parenchymal transection is as safe as Harmonic scalpel device. outcomes will include: perioperative mortality, surgery-related complications, blood loss, amount of blood loss during hepatectomy, operating time, transection speed, markers of liver parenchymal injury and hospital stay.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Liver right lobe donors

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Harmonic scalpel
a method for liver parenchymal transection
Kelly clamp crush technique
a method for liver parenchymal transection

Locations

Country Name City State
Egypt Gastro-enterolgy surgical center, Mansoura University Mansoura Al-Dakahleia

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary blood loss during hepatectomy bleeding during transection phase will be calculated in mL. based on the blood in the sucker machine and the surgical towels intraoperative
Secondary transection speed the transection speed will be calculated in minutes based on the relation between the transecition time divided by the surface area of the raw area of the graft measured on the backtable. intraoperative
Secondary liver pathology from the cut margin the area of necrosis will be measured in millimeters by the pathologist intraoperative
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05047406 - Bacillus Clausii in Liver Transplantation Phase 2
Completed NCT03174327 - Evaluation of Hepatic Rigidity by Ultrasonic Impulse Elastography in Liver Transplant Patients N/A
Completed NCT01388387 - Pharmacogenetic Study of Tacrolimus in Hepatic Transplant (CYPTAC'H) N/A